Style
—Turnover
Orientation
Concentrated long-term| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Oruka Therapeutics Inc(ORKA) | 1,565,661 | $149.0M | 32.99% |
| 2 | Spyre Therapeutics Inc(SYRE) | 1,464,169 | $130.0M | 28.78% |
| 3 | Apogee Therapeutics Inc(APGE) | 586,691 | $77.9M | 17.24% |
| 4 | Damora Therapeutics Inc(GLTO) | 2,045,473 | $53.2M | 11.78% |
| 5 | Jade Biosciences Inc(JBIO) | 1,577,750 | $35.1M | 7.76% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 97.64% | 100% | +2.36% |
| Unclassified | 2.36% | 0% | -2.36% |
Quarter-over-quarter weight changes by market cap
| Cap Size | Prev % | Curr % |
|---|
Quarter-over-quarter position changes
| 6 |
| Crescent Biopharma Inc(CBIO) |
| 361,250 |
| $6.5M |
| 1.44% |
| Change |
|---|
| Small Cap | 54.04% | 53.98% | -0.06% |
| Mid Cap | 43.6% | 46.02% | +2.42% |
| Unclassified | 2.36% | 0% | -2.36% |